BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...oncolytic virus to treat solid tumors.5Y Capital backs pair of Chinese AI companies5Y Capital (formerly Morningside Venture Capital...
BioCentury | Dec 1, 2020
Product Development

Nov. 30 Quick Takes: Grail piloting blood test in U.K.; plus Rhythm, Kadmon, venture rounds for Adrenomed, Xbiome, Transition

...a series B+ financing round co-led by Primavera Capital and Gaorong Capital with participation by Morningside Venture Capital...
BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...in an undisclosed round co-led by Tencent, GL Ventures and YF Capital with participation by Morningside Venture Capital...
BioCentury | May 31, 2019
Company News

Vigeo debuts to reprogram tumor microenvironment

...Vigeo emerged from stealth Friday with $27.5 million from Morningside Venture Capital and a cancer candidate already in...
BioCentury | Feb 21, 2019
Financial News

Shukun raises RMB200M series B round for AI diagnostics

...million ($29.6 million) series B round led by China Creation Ventures. Two A round investors, Morningside Venture Capital...
BioCentury | May 25, 2018
Financial News

Immunoproteasome company Kezar files for $80.5M IPO

...last year led by Cormorant Asset Management and Morningside Ventures. Allison Johnson KZR-616 Amgen Inc. Cormorant Asset Management Kezar Life Sciences Morningside Venture Capital Onyx...
Items per page:
1 - 6 of 6
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...oncolytic virus to treat solid tumors.5Y Capital backs pair of Chinese AI companies5Y Capital (formerly Morningside Venture Capital...
BioCentury | Dec 1, 2020
Product Development

Nov. 30 Quick Takes: Grail piloting blood test in U.K.; plus Rhythm, Kadmon, venture rounds for Adrenomed, Xbiome, Transition

...a series B+ financing round co-led by Primavera Capital and Gaorong Capital with participation by Morningside Venture Capital...
BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...in an undisclosed round co-led by Tencent, GL Ventures and YF Capital with participation by Morningside Venture Capital...
BioCentury | May 31, 2019
Company News

Vigeo debuts to reprogram tumor microenvironment

...Vigeo emerged from stealth Friday with $27.5 million from Morningside Venture Capital and a cancer candidate already in...
BioCentury | Feb 21, 2019
Financial News

Shukun raises RMB200M series B round for AI diagnostics

...million ($29.6 million) series B round led by China Creation Ventures. Two A round investors, Morningside Venture Capital...
BioCentury | May 25, 2018
Financial News

Immunoproteasome company Kezar files for $80.5M IPO

...last year led by Cormorant Asset Management and Morningside Ventures. Allison Johnson KZR-616 Amgen Inc. Cormorant Asset Management Kezar Life Sciences Morningside Venture Capital Onyx...
Items per page:
1 - 6 of 6